{140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack

RxCUI: 1729075
RxNorm name: {140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack
Display name: {140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack
Full name: {140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:39:13

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UPTRAVI	SELEXIPAG	Actelion Pharmaceuticals US, Inc.	a7a23b87-f892-4e2c-8e2e-ebf841220f90	2026-05-28	Warnings, Adverse reactions	Exact identifier rxcui: 1729075
Selexipag	SELEXIPAG	Zydus Lifesciences Limited	ff660787-880f-4f2b-baac-fd2dbfcd79c2	2025-11-07	Warnings, Adverse reactions	Exact identifier rxcui: 1729075
Selexipag	SELEXIPAG	Zydus Pharmaceuticals (USA) Inc.	c604e181-e336-4194-bf96-f65dd164d461	2024-05-25	Warnings, Adverse reactions	Exact identifier rxcui: 1729075

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a7a23b87-f892-4e2c-8e2e-ebf841220f90	{140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack [GPCK] · selexipag 200 MCG (140), selexipag 800 MCG (60) Oral Tablet Titration Pack [PSN] · {140 (selexipag 200 MCG Oral Tablet) / 60 (selexipag 800 MCG Oral Tablet) } Pack [SY]	3	26	These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015	20260528
c604e181-e336-4194-bf96-f65dd164d461	{140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack [GPCK] · selexipag 200 MCG (140), selexipag 800 MCG (60) Oral Tablet Titration Pack [PSN] · {140 (selexipag 200 MCG Oral Tablet) / 60 (selexipag 800 MCG Oral Tablet) } Pack [SY]	3	3	These highlights do not include all the information needed to use SELEXIPAG TABLETS safely and effectively. See full prescribing information for SELEXIPAG TABLETS. SELEXIPAG tablets, for oral use Initial U.S. Approval: 2015	20240525
ff660787-880f-4f2b-baac-fd2dbfcd79c2	{140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack [GPCK] · selexipag 200 MCG (140), selexipag 800 MCG (60) Oral Tablet Titration Pack [PSN] · {140 (selexipag 200 MCG Oral Tablet) / 60 (selexipag 800 MCG Oral Tablet) } Pack [SY]	3	2	These highlights do not include all the information needed to use SELEXIPAG TABLETS safely and effectively. See full prescribing information for SELEXIPAG TABLETS. SELEXIPAG tablets, for oral use Initial U.S. Approval: 2015	20251107